Cytogenetic Study in Therapy-Related Myelodysplastic Syndromes and Acute Non-Lymphocytic Leukaemia
Author Information
Author(s): G. Sozzi, M. Miozzo, A. Orazi, C. Calderone, M. Castellano, S. Viviani, A. Santoro, M.A. Pierotti, G. Della Porta
Primary Institution: Istituto Nazionale Tumori, Milan, Italy
Hypothesis
The study aims to characterize chromosome changes in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL).
Conclusion
Abnormalities of chromosomes 5 and/or 7 are frequently observed in secondary haematological disorders and could be of diagnostic and prognostic value.
Supporting Evidence
- All 12 patients with t-MDS and t-ANLL showed chromosome abnormalities.
- Chromosome 5 was the most frequently rearranged chromosome.
- Mean survival time from the diagnosis of the secondary disorder was 6.4 months.
Takeaway
Doctors looked at the chromosomes of patients who got sick after cancer treatment and found that changes in certain chromosomes could help understand their illness better.
Methodology
The study involved cytogenetic analysis of bone marrow and peripheral blood samples from patients with a history of chemotherapy and/or radiotherapy.
Limitations
The small sample size limits the ability to make broad conclusions.
Participant Demographics
The study included 27 adult patients with a history of chemotherapy and/or radiotherapy.
Want to read the original?
Access the complete publication on the publisher's website